Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,368 public trials 1,306 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014)

NCT06052566

Conditions
Digestive System Diseases, Fatty Liver, Hepatic Impairment, +3 more
Locations
  • Clinical Pharmacology of Miami ( Site 0005) Miami, Florida, United States
  • Advanced Pharma CR, LLC ( Site 0001) Miami, Florida, United States
  • Genesis Clinical Research, LLC ( Site 0006) Tampa, Florida, United States
  • American Research Corporation ( Site 0002) San Antonio, Texas, United States
View Trial Details
Completed

A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV

NCT05904470

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +19 more
Locations
  • Atea Study Site San Antonio, Texas, United States
  • Atea Study Site Manaus, Amazonas, Brazil
  • Atea Study Site Salvador, Estado de Bahia, Brazil
  • Atea Study Site Brasília, Federal District, Brazil
View all 51 locations
View Trial Details
Completed

A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC)

NCT03412773

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • UCLA Hematologyoncology Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 122 locations
View Trial Details
Completed

Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH

NCT06104319

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • GSK Investigational Site Chula Vista, California, United States
  • GSK Investigational Site Montclair, California, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site San Diego, California, United States
View all 14 locations
View Trial Details
Completed

A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

NCT05293496

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View Trial Details

Related conditions